Pear Bio
Patient-centered cancer precision medicine
10 employees · est. 2017 · London, United Kingdom
Vevo Therapeutics
We are combining in vivo data and AI to find better targets and drugs that can treat more patients.
25 employees · est. 2022
Pear Bio is the older company (2017 vs 2022); Vevo Therapeutics is the larger of the two.
Side-by-Side Comparison
| Metric | Pear Bio | Vevo Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2017 older | 2022 |
| Headquarters | ||
| Headquarters | London, United Kingdom | Not tracked yet |
| Employees | ||
| Employees | 10 | 25 larger |
| Industry | ||
| Industry | Biotechnology, Health Care | AI, Biotechnology, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Series A | Seed |
| Total Funding | ||
| Total Funding | $19.79M | $12.00M |
| Funding Rounds | ||
| Funding Rounds | 9 | 1 |
| Services | ||
| Services | Personalized Testing Services, Drug Discovery | Not tracked yet |
| Target Customers | ||
| Target Customers | Cancer Patients, Oncologists, Biopharmaceutical Companies, Medical Researchers | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Precision Medicine, Cancer Biology, Functional Genomics, 3D Microtumor Platforms, Computational Biology, Drug Discovery, Biomarker Development, AI In Oncology, Ex Vivo Testing, Multi-omics, Immune-Microtumors, Patient-Centric Therapies, Image-Based Biomarkers, 3D Computer Vision, Therapeutic Development | In Vivo Data, Drug Discovery, Mosaic Platform, Single-cell Precision, Patient Diversity, In Vivo Atlas, Genomics, Computational Biology, Chemistry, San Francisco, Investors, Life Sciences, Technology |
| Website | ||
| Website | pearbio.com | vevo.ai |
About Pear Bio
Pear Bio, founded in 2017 and headquartered in the United Kingdom, is making strides in the fields of Biotechnology and Health Care with its focus on Patient-centered cancer precision medicine. The company employs a proprietary computational biology platform to unravel intricate cancer biology, faci...
About Vevo Therapeutics
Vevo Therapeutics is a biotechnology startup founded in 2022, with a mission to revolutionize drug discovery using in vivo data and AI. The company's Mosaic platform is pioneering in capturing in vivo context of diseases with single-cell precision, enabling a more accurate representation of patient...
We will tell you when either one moves
BounceWatch watches Pear Bio and Vevo Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Pear Bio and Vevo Therapeutics — by email.
Frequently Asked Questions
Compare Pear Bio with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Pear Bio on 15 Jun 2026, and Vevo Therapeutics on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.